The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABEONA THERAPEUTICS INC | COMM | 00289Y206 | 3,943,819 | 624,022 | SH | DFND | 1 | 215,438 | 408,584 | 0 | ||
| ACHIEVE LIFE SCIENCES INC | COMM | 004468500 | 11,627,656 | 2,453,092 | SH | DFND | 1 | 2,235,247 | 217,845 | 0 | ||
| AKERO THERAPEUTICS INC | COMM | 00973Y108 | 9,861,585 | 343,729 | SH | DFND | 1 | 115,275 | 228,454 | 0 | ||
| APPLIED THERAPEUTICS INC | COMM | 03828A101 | 55,826,793 | 6,567,858 | SH | DFND | 1 | 3,750,353 | 2,817,505 | 0 | ||
| ARDELYX INC | COMM | 039697107 | 7,378,825 | 1,070,947 | SH | DFND | 1 | 381,583 | 689,364 | 0 | ||
| AVIDITY BIOSCIENCES INC | COMM | 05370A108 | 8,198,505 | 178,500 | SH | DFND | 1 | 53,500 | 125,000 | 0 | ||
| CHINOOK THERAPEUTICS | COMM | 169CVR016 | 9,750 | 79,357 | SH | DFND | 1 | 54,357 | 25,000 | 0 | ||
| COMPASS PATHWAYS LTD | COMM | 20451W101 | 504,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| EIGER BIOPHARMACEUTICALS | COMM | 28249U204 | 1,244,239 | 146,381 | SH | DFND | 1 | 56,381 | 90,000 | 0 | ||
| KURA ONCOLOGY INC | COMM | 50127T109 | 2,540,200 | 130,000 | SH | DFND | 1 | 50,000 | 80,000 | 0 | ||
| KYMERA THERAPEUTICS INC | COMM | 501575104 | 2,667,471 | 56,359 | SH | DFND | 1 | 25,844 | 30,515 | 0 | ||
| MADRIGAL PHARMACEUTICALS | COMM | 558868105 | 9,132,251 | 43,032 | SH | DFND | 1 | 19,738 | 23,294 | 0 | ||
| PHATHOM PHARMACEUTICALS I | COMM | 71722W107 | 15,728,280 | 869,927 | SH | DFND | 1 | 347,992 | 521,935 | 0 | ||
| SYNDAX PHARMACEUTICALS IN | COMM | 87164F105 | 2,565,236 | 133,259 | SH | DFND | 1 | 53,259 | 80,000 | 0 | ||
| TSCAN THERAPEUTICS INC | COMM | 89854M101 | 10,393,952 | 2,087,139 | SH | DFND | 1 | 1,040,223 | 1,046,916 | 0 | ||
| VERRICA PHARMACEUTICALS I | COMM | 92511W108 | 500,159 | 344,937 | SH | DFND | 1 | 144,937 | 200,000 | 0 | ||
| ZEVRA THERAPEUTICS INC | COMM | 488445206 | 1,248,326 | 179,874 | SH | DFND | 1 | 59,874 | 120,000 | 0 | ||
| MAAT PHARMA SACA | COMM | F5888J116 | 17,786 | 2,397 | SH | DFND | 1 | 0 | 2,397 | 0 | ||
| TELESAT CORP | COMM | 879512309 | 4,817,336 | 365,781 | SH | DFND | 1 | 0 | 365,781 | 0 | ||
| ATHIRA PHARMA INC | COMM | 04746L104 | 665,785 | 1,492,792 | SH | DFND | 1 | 0 | 1,492,792 | 0 | ||
| PLAINS GP HOLDINGS LP-CL | COMM | 72651A207 | 23,538,660 | 1,272,360 | SH | DFND | 1 | 0 | 1,272,360 | 0 | ||